News & Analysis

TIBCO Spotfire Webcast to Provide Life Science Companies With Key Insights Into Increasing Efficiency in Clinical Development

TIBCO Software Inc. (NASDAQ: TIBX) today announced that Ben McGraw, director of life science industry solutions, TIBCO Spotfire(R), is hosting a complimentary webcast on Thursday, December 15, 2011 titled "Increase Efficiency in Clinical Development Using TIBCO Spotfire." The webcast will discuss how life science companies can use TIBCO Spotfire to uncover trends, patterns and unexpected insights hidden in clinical, operational and safety data to get safe products to market faster and ensure greater regulatory compliance, while also reducing clinical development costs.

What/When: "Increase Efficiency in Clinical Development Using TIBCO Spotfire" webcast -- Thursday, December 15, 2011 at 11:00 a.m. EST.

Using TIBCO Spotfire, life science companies can identify new opportunities and detect emerging trends using interactive dashboards, analytic applications and data visualizations, enabling their clinical development teams to act on answers to relevant questions at the speed of thought. TIBCO Spotfire equips a broad spectrum of life science users with an enterprise analytics platform to visually analyze clinical, operational and safety data without manual review of data using paper, spreadsheets or antiquated and static business intelligence reports.

During the webcast, Mr. McGraw will help attendees learn:

--  How business users can perform self-service discovery in the following
    areas: in stream safety assessments, protocol adherence, data
    cleaning, site reporting, patient enrollment, clinical supplies, study
    budgeting and post marketing surveillance in a way that complements
    clinical development IT and biostatistics;
--  How leading life science companies have utilized TIBCO Spotfire to
    explore hidden opportunities in their data so that molecules can be
    efficiently developed or terminated; and
--  How to keep a tight and transparent handle on designated medical
    events and highlighted sites not adhering to protocol, and evaluate
    protocols for new studies based on exploratory analyses from studies
    in similar populations.

Information: To register for the webcast, please visit: http://spotfire2.tibco.com/l/5772/2011-11-23/27FVG.

To learn more about how TIBCO Spotfire's analytics capabilities can empower life science organizations to make smarter business decisions, please visit: http://spotfire.tibco.com/spotfire-for-you/by-industry/life-sciences/life-sciences-analytics.aspx.

About TIBCO TIBCO Software Inc. (NASDAQ: TIBX) is a provider of infrastructure software for companies to use on-premise or as part of cloud computing environments. Whether it's efficient claims or trade processing, cross-selling products based on real-time customer behavior, or averting a crisis before it happens, TIBCO provides companies the two-second advantage(TM) -- the ability to capture the right information, at the right time and act on it preemptively for a competitive advantage. More than 4,000 customers worldwide rely on TIBCO to manage information, decisions, processes, and applications in real-time. TIBCO Spotfire(R) is the company's in-memory analytics software for next generation business intelligence. By offering a visual, interactive experience, Spotfire(R) helps professionals quickly discover new and actionable insights in information. Learn more at http://spotfire.tibco.com.

TIBCO, TIBCO Software, TIBCO Spotfire, Spotfire, and two-second advantage are trademarks or registered trademarks of TIBCO Software Inc. or its subsidiaries in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.

Media Inquiries
Amy Groden-Morrison
TIBCO Software Inc.
617-702-1710
Email Contact
http://spotfire.tibco.com

Meghan Locke 
Davies Murphy Group
781-418-2434
Email Contact 
http://daviesmurphy.com 

SOURCE: TIBCO Software Inc.